Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

BIO-MED BIOMATERIALS : revenue, balance sheet and financial ratios

BIO-MED BIOMATERIALS is a French company founded 28 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in RAMONVILLE-SAINT-AGNE (31520), this company of category PME shows in 2017 a net income negative of -565€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - BIO-MED BIOMATERIALS (SIREN 418137444)
Indicator 2017 2016
Revenue N/C N/C
Net income -565 € 7 973 €
EBITDA N/C N/C
Net margin N/C N/C

Revenue and income statement

In 2017, BIO-MED BIOMATERIALS records a net loss of 565 €. This deficit will reduce equity on the balance sheet.

Net income (2017) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-565 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 44%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 59%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2017) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

44.251%

Financial autonomy (2017) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

59.427%

Asset age ratio (2017) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

10.2%

Solvency indicators evolution
BIO-MED BIOMATERIALS

Sector positioning

Debt ratio
44.25 2017
2016
2017
Q1: 0.0
Med: 6.83
Q3: 49.59
Average

In 2017, the debt ratio of BIO-MED BIOMATERIALS (44.25) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
59.43% 2017
2016
2017
Q1: 14.21%
Med: 37.04%
Q3: 60.18%
Good

In 2017, the financial autonomy of BIO-MED BIOMATERIALS (59.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 688.77. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2017) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

688.772

Liquidity indicators evolution
BIO-MED BIOMATERIALS

Sector positioning

Liquidity ratio
688.77 2017
2016
2017
Q1: 131.18
Med: 189.43
Q3: 305.54
Excellent

In 2017, the liquidity ratio of BIO-MED BIOMATERIALS (688.77) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of BIO-MED BIOMATERIALS in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare BIO-MED BIOMATERIALS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about BIO-MED BIOMATERIALS

What is the revenue of BIO-MED BIOMATERIALS ?

The revenue of BIO-MED BIOMATERIALS is not publicly disclosed (confidential accounts filed with INPI).

Is BIO-MED BIOMATERIALS profitable?

BIO-MED BIOMATERIALS recorded a net loss in 2017.

Where is the headquarters of BIO-MED BIOMATERIALS ?

The headquarters of BIO-MED BIOMATERIALS is located in RAMONVILLE-SAINT-AGNE (31520), in the department Haute-Garonne.

Where to find the tax return of BIO-MED BIOMATERIALS ?

The tax return of BIO-MED BIOMATERIALS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does BIO-MED BIOMATERIALS operate?

BIO-MED BIOMATERIALS operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.